← Evidence map

ArticleDrug safety2026

Authors' Response to Weng et al.'s Comment on "Association of GLP1-Receptor Agonists with Risk of Hepatocellular Carcinoma: A Retrospective Cohort Study".

Ishak A Mansi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Authors' Response to Weng et al.'s Comment on "Association of GLP1-Receptor Agonists with Risk of Hepatocellular Carcinoma: A Retrospective Cohort Study". | Socratic